Private EquityRIA · CRD 313459Exempt Reporting AdviserPrivate Fund Adviser

Updated:

Meridian Street Capital

Meridian Street Capital engineers the future of healthcare alongside early stage trailblazers. They help turn the best ideas in healthcare into...

Meridian Street Capital logo

Meridian Street Capital

Meridian Street Capital engineers the future of healthcare alongside early stage trailblazers. They help turn the best ideas in healthcare into category-defining companies. They deliberately invest at the intersection of healthcare and technology and support founders often from day one as steadfast partners to a concentrated group.

General information

Firm type

Private Equity

Year founded

2016

Location

Region

North America

Country

United States

City

New York

Corporate office

New York, United States

Principals

Scott Law

Partner

George Ribaroff, MD

Partner

Jimmy Comfort

Venture Partner

Sector focus

Digital Health

Frequently asked questions

Who runs investment decisions at Meridian Street Capital?

Partners Scott Law and George Ribaroff, MD lead the investment function, per the firm’s website. Dr. Ribaroff’s clinical background — he holds an MD — anchors the firm’s ability to evaluate healthcare sciences. Venture Partner Jimmy Comfort extends the reach into deal sourcing and portfolio support.

What investment stages does Meridian Street Capital typically target?

The firm targets the earliest stages of company formation, explicitly supporting founders 'often from day one.' Its stated focus encompasses seed, start-up, and early-stage healthcare-technology ventures, moving deliberately to shape category-defining companies before traditional venture-scale syndicates commit.

Which sectors does Meridian Street Capital explicitly pursue?

The firm invests deliberately and solely at the intersection of healthcare and technology. It does not publish a broader sector mandate, distinguishing itself from generalist early-stage funds by concentrating exclusively on this vertical.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on private equity firms?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

Browse by category

More New York Private Equity profiles